Treatment of the avascular necrosis with a novel biodegradable thermosensitive Box hydrogel carrying BMP-2

Meng Yow Hsieh, Liang Yo Yang, Jia Ming Chern, Wen Fu Lee, Yi You Huang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Avascular necrosis (AVN) is the death of bone tissue due to a lack of blood supply. Also called osteonecrosis, avascular necrosis can lead to tiny breaks in bone and eventual bone collapse. As people age, the risk of becoming a victim to osteonecrosis gets higher and higher. However, there is still no reliable treatment for the early stage of AVN. In this study, we first established a reliable AVN animal model by sham AVN surgery plus methylprednisolone (MP) treatment and then investigated the effect of Bone Morphogenetic Protein-2 (BMP-2) on treating femoral head with the induced avascular necrosis. Our results showed that AVN surgery plus MP treatment has successfully reduced the damage of femoral head 4 weeks after treatment. A dosage of BMP-2 (1 μg/mL) in hydrogel has effectively reduced the femoral damage induced by AVN surgery plus MP treatment by preserving more epiphysis of the femoral head and more trabeculae below the growth plate of the femoral head 8 weeks after treatment. Furthermore, BMP-2 in hydrogel attenuated the femoral head damage after AVN surgery plus MP treatment at doses of 1 and 2 μg/mL. These findings strongly suggest that BMP-2 in the hydrogel has a great potential for treating patients suffering from avascular necrosis or other conditions characterized by the osteonecrosis of bones.

Original languageEnglish
Pages (from-to)815-823
Number of pages9
JournalScience of Advanced Materials
Volume9
Issue number5
DOIs
Publication statusPublished - 2017

Fingerprint

Bone Morphogenetic Protein 2
Hydrogel
Methylprednisolone
Hydrogels
Surgery
Bone
Proteins
Animals
Blood
Tissue

Keywords

  • Avascular Necrosis
  • Bone Morphogenetic Protein-2 (BMP-2)
  • Hydrogel
  • Methylprednisolone
  • Osteonecrosis

ASJC Scopus subject areas

  • Materials Science(all)

Cite this

Treatment of the avascular necrosis with a novel biodegradable thermosensitive Box hydrogel carrying BMP-2. / Hsieh, Meng Yow; Yang, Liang Yo; Chern, Jia Ming; Lee, Wen Fu; Huang, Yi You.

In: Science of Advanced Materials, Vol. 9, No. 5, 2017, p. 815-823.

Research output: Contribution to journalArticle

Hsieh, Meng Yow ; Yang, Liang Yo ; Chern, Jia Ming ; Lee, Wen Fu ; Huang, Yi You. / Treatment of the avascular necrosis with a novel biodegradable thermosensitive Box hydrogel carrying BMP-2. In: Science of Advanced Materials. 2017 ; Vol. 9, No. 5. pp. 815-823.
@article{57eb0269bb874ee3852eedcbe78e5c5d,
title = "Treatment of the avascular necrosis with a novel biodegradable thermosensitive Box hydrogel carrying BMP-2",
abstract = "Avascular necrosis (AVN) is the death of bone tissue due to a lack of blood supply. Also called osteonecrosis, avascular necrosis can lead to tiny breaks in bone and eventual bone collapse. As people age, the risk of becoming a victim to osteonecrosis gets higher and higher. However, there is still no reliable treatment for the early stage of AVN. In this study, we first established a reliable AVN animal model by sham AVN surgery plus methylprednisolone (MP) treatment and then investigated the effect of Bone Morphogenetic Protein-2 (BMP-2) on treating femoral head with the induced avascular necrosis. Our results showed that AVN surgery plus MP treatment has successfully reduced the damage of femoral head 4 weeks after treatment. A dosage of BMP-2 (1 μg/mL) in hydrogel has effectively reduced the femoral damage induced by AVN surgery plus MP treatment by preserving more epiphysis of the femoral head and more trabeculae below the growth plate of the femoral head 8 weeks after treatment. Furthermore, BMP-2 in hydrogel attenuated the femoral head damage after AVN surgery plus MP treatment at doses of 1 and 2 μg/mL. These findings strongly suggest that BMP-2 in the hydrogel has a great potential for treating patients suffering from avascular necrosis or other conditions characterized by the osteonecrosis of bones.",
keywords = "Avascular Necrosis, Bone Morphogenetic Protein-2 (BMP-2), Hydrogel, Methylprednisolone, Osteonecrosis",
author = "Hsieh, {Meng Yow} and Yang, {Liang Yo} and Chern, {Jia Ming} and Lee, {Wen Fu} and Huang, {Yi You}",
year = "2017",
doi = "10.1166/sam.2017.3026",
language = "English",
volume = "9",
pages = "815--823",
journal = "Science of Advanced Materials",
issn = "1947-2935",
publisher = "American Scientific Publishers",
number = "5",

}

TY - JOUR

T1 - Treatment of the avascular necrosis with a novel biodegradable thermosensitive Box hydrogel carrying BMP-2

AU - Hsieh, Meng Yow

AU - Yang, Liang Yo

AU - Chern, Jia Ming

AU - Lee, Wen Fu

AU - Huang, Yi You

PY - 2017

Y1 - 2017

N2 - Avascular necrosis (AVN) is the death of bone tissue due to a lack of blood supply. Also called osteonecrosis, avascular necrosis can lead to tiny breaks in bone and eventual bone collapse. As people age, the risk of becoming a victim to osteonecrosis gets higher and higher. However, there is still no reliable treatment for the early stage of AVN. In this study, we first established a reliable AVN animal model by sham AVN surgery plus methylprednisolone (MP) treatment and then investigated the effect of Bone Morphogenetic Protein-2 (BMP-2) on treating femoral head with the induced avascular necrosis. Our results showed that AVN surgery plus MP treatment has successfully reduced the damage of femoral head 4 weeks after treatment. A dosage of BMP-2 (1 μg/mL) in hydrogel has effectively reduced the femoral damage induced by AVN surgery plus MP treatment by preserving more epiphysis of the femoral head and more trabeculae below the growth plate of the femoral head 8 weeks after treatment. Furthermore, BMP-2 in hydrogel attenuated the femoral head damage after AVN surgery plus MP treatment at doses of 1 and 2 μg/mL. These findings strongly suggest that BMP-2 in the hydrogel has a great potential for treating patients suffering from avascular necrosis or other conditions characterized by the osteonecrosis of bones.

AB - Avascular necrosis (AVN) is the death of bone tissue due to a lack of blood supply. Also called osteonecrosis, avascular necrosis can lead to tiny breaks in bone and eventual bone collapse. As people age, the risk of becoming a victim to osteonecrosis gets higher and higher. However, there is still no reliable treatment for the early stage of AVN. In this study, we first established a reliable AVN animal model by sham AVN surgery plus methylprednisolone (MP) treatment and then investigated the effect of Bone Morphogenetic Protein-2 (BMP-2) on treating femoral head with the induced avascular necrosis. Our results showed that AVN surgery plus MP treatment has successfully reduced the damage of femoral head 4 weeks after treatment. A dosage of BMP-2 (1 μg/mL) in hydrogel has effectively reduced the femoral damage induced by AVN surgery plus MP treatment by preserving more epiphysis of the femoral head and more trabeculae below the growth plate of the femoral head 8 weeks after treatment. Furthermore, BMP-2 in hydrogel attenuated the femoral head damage after AVN surgery plus MP treatment at doses of 1 and 2 μg/mL. These findings strongly suggest that BMP-2 in the hydrogel has a great potential for treating patients suffering from avascular necrosis or other conditions characterized by the osteonecrosis of bones.

KW - Avascular Necrosis

KW - Bone Morphogenetic Protein-2 (BMP-2)

KW - Hydrogel

KW - Methylprednisolone

KW - Osteonecrosis

UR - http://www.scopus.com/inward/record.url?scp=85018317544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018317544&partnerID=8YFLogxK

U2 - 10.1166/sam.2017.3026

DO - 10.1166/sam.2017.3026

M3 - Article

AN - SCOPUS:85018317544

VL - 9

SP - 815

EP - 823

JO - Science of Advanced Materials

JF - Science of Advanced Materials

SN - 1947-2935

IS - 5

ER -